# Shinhan Capital

> Shinhan Capital is a VC fund backing Information Technology and Software. See 197 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 197
- Last investment: Jun 2026
- Lead investor: 4%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/shinhan-capital-co-ltd-/about/
- Website: https://www.shcap.co.kr

Shinhan Capital is a credit-specialized company offering corporate finance services for its clients. It provides financial services, lease, corporate loans, investment financing, housing loans, installment financing, etc. Shinhan Capital was established in 1991. The company is headquartered in Seoul, South Korea.

## Contacts

5 contacts available for Shinhan Capital. Shizune tracks 3 team members at Shinhan Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/shinhan-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $347k–$4M |
| Series A | $2.1M–$13M |
| Series B | $3.7M–$18M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Information Technology | 22 | 11% |
| Software | 15 | 8% |
| E-Commerce | 12 | 6% |
| Health Care | 12 | 6% |
| Apps | 11 | 6% |

184 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 47 | 24% |
| Seed | 33 | 17% |
| Series B | 33 | 17% |
| Series C | 8 | 4% |
| Funding Round | 8 | 4% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 108 | 55% |
| United States | 4 | 2% |
| India | 1 | 1% |
| Japan | 1 | 1% |
| Iceland | 1 | 1% |

9 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Heo Young Taeg | CEO | 0 | https://shizune.co/investors/profile/heo-young-taeg |
| Hyung-Seok Ha | Senior Manager | 1 | https://shizune.co/investors/profile/hyung-seok-ha |
| Lee Dong- hwan | directing manager | 2 | https://shizune.co/investors/profile/lee-dong-hwan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nventric | Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications. | $22.6M | Venture - Series Unknown | Jun 10, 2026 |  |
| Spark Biopharma | SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring anddeveloping new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. ' | $21.4M | Venture - Series Unknown | May 11, 2026 |  |
| Mustbio | MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea. | $23.3M | Series C | Mar 13, 2026 |  |
| Plastal | Plastal is a mechanical and chemical engineering company that offers polymer, metal, and mold injection services. The company specializes in using its core technology required for bonding between metal and plastic resin, mold technology, injection conditions, and milling capabilities, enabling manufacturing companies to avail themselves of theproducts they desire. | $13.1M | Series B | Oct 16, 2025 |  |
| IMBiologics | IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M | Series C | Oct 14, 2025 |  |
| Novacos | Novacos develops cosmetic and skincare products through OEM and ODM manufacturing. The company handles formulation development, product production, packaging, quality control, and private-label cosmetics services. | $1.4M | Seed | Oct 01, 2025 |  |
| Rose Lab | Rose Lab is a bioremediation and cosmetic medical device manufacturing company that provides research on bioremediation products. The company aims to become a specialized medical company leading the development of innovative materials for safe clinical application and the convergence of medicine, life science, polymer chemistry, and newtechnologies, for the health and beautiful lives of humanity. Rose Lab solve problems through a shift in perspective and creative thinking. | $7.2M | Series B | Sep 01, 2025 |  |
| Trioar | Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs. | $16.2M | Series B | Jul 17, 2025 |  |
| Curiosis | Curiosis’s expert team of scientists and engineers are dedicated to develop high efficiency instruments by using core technologies of biophysics and electronic engineering. Providing cutting edge technologies and optimized platform allow the researchers to challenging their progress improvement. | $9.6M |  | Oct 14, 2024 |  |
| Global Technologies | Global Technologies specializes in developing core sensors and advanced sensor systems. Leveraging proprietary semiconductor and software technology, they provide high-performance solutions for environmental sensing and industrial applications. Based in Korea, the company focuses on innovation in sensor hardware to enable smarter data collectionand automation across various global markets. | $9.4M | Series A | Jul 04, 2024 |  |

10 of 197 investments shown.

## Co-investors
- [FuturePlay](https://shizune.co/investors/profile/futureplay-co) — VC Fund, 30 deals together
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund, 28 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 18 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 16 deals together
- [Timepolio Asset Management](https://shizune.co/investors/profile/timepolio-asset-management) — VC Fund, 13 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 9 deals together

## Similar investors

### Similar industry
- [RRE Ventures](https://shizune.co/investors/profile/rre-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [1745 Ventures](https://shizune.co/investors/profile/bertelsmann-digital-media-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [All Investors in South Korea](https://shizune.co/investors/investors-south-korea)
- [All VC Funds in South Korea](https://shizune.co/investors/vc-funds-south-korea)
- [SaaS Investors in South Korea](https://shizune.co/investors/saas-investors-south-korea)
- [SaaS VC Funds in South Korea](https://shizune.co/investors/saas-vc-funds-south-korea)
- [Enterprise Investors in South Korea](https://shizune.co/investors/enterprise-investors-south-korea)
- [Enterprise VC Funds in South Korea](https://shizune.co/investors/enterprise-vc-funds-south-korea)

## FAQ

### What does Shinhan Capital invest in?

Shinhan Capital invests primarily in Information Technology, Software and E-Commerce startups, most often at Series A and Seed stage. Most of the 197 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Shinhan Capital's check size?

Shinhan Capital typically joins rounds of $347k–$4M at Seed, $2.1M–$13M at Series A and $3.7M–$18M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shinhan Capital participates in.

### How do I contact Shinhan Capital?

Public channels for Shinhan Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Shinhan Capital?

The team at Shinhan Capital includes Heo Young Taeg (CEO), Hyung-Seok Ha (Senior Manager) and Lee Dong- hwan (directing manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co